Buy Orlistat Powder for Weight Lose API
|FOB Price:||US $1 / g|
|Min. Order:||10 g|
|Min. Order||FOB Price|
|10 g||US $1/ g|
|Payment Terms:||T/T, Western Union, Money Gram, bitcoin|
- Model NO.: Orlistat Powder
- Customized: Customized
- Suitable for: Adult
- Purity: >99%
- CAS No: 96829-58-2
- MW: 495.73
- Appearance: White Needle Crystal or Powder
- Orlistat Packing: Discreet Package
- Trademark: Hongkong Shijingu Technology Co., Ltd.
- Specification: GMP/ISO9001/USP
- HS Code: 3001200020
- Powder: Yes
- Certification: SGS
- State: Powder
- Name: Orlistat
- Mf: C29h53no5
- Assay: 99%
- Export Markets: Global
- Source: Orlistat Powder Supplier
- Transport Package: Foil Bag /Drum/ Vails
- Origin: Made in China
CAS No.: 96829-58-2
Molecular Formula: C29H53NO5
Molecular Weight: 495.73
Appearance: White needle crystal or powder,soluble in water.
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
1.Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity,is internationally recognized as a new type of lipid-lowering drugs to lose weight.
2.it primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet
3.Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini.However.
4.Due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug